In SLE, the percentage of peripheral CD11c+T-bet+ B cells is closely associated with pathological conditions such as the production of anti-ds-DNA/SM/RNP and other antibodies, disease activity, and renal damage (9). Here, ITGAX is linked to systemic lupus erythematosus.